| Similar Articles |
|---|
 |
Geotimes
May 2004
Megan Sever |
French Science Crisis On March 9, more than 2,000 French science research laboratory directors and team leaders tendered their resignations of administrative and management duties in protest over what they call "draconian cuts" in government scientific spending and research jobs.   |
InternetNews
May 2, 2006
Sean Michael Kerner |
Chambers: The Network Is The Platform Forget the operating system. Cisco CEO John Chambers says the network will drive Internet-based communications. |
The Motley Fool
August 11, 2010
Brian Orelli |
Dang! This Drug Is Shining Brighter Vertex illuminates telaprevir's additional benefit in treating hepatitis C patients. |
The Motley Fool
February 22, 2011
Brian Orelli |
Biogen and Elan's Growing Problem More cases of potentially lethal PML. |
BusinessWeek
March 29, 2004 |
A Bold Move By Paris And China? The French aerospace and defense industries see China as a potentially lucrative market. But sales of French missiles and other defense products would raise concerns in Washington, which still restricts technology sales to China. |
Fast Company
September 14, 2011
Emma Haak |
Global E-Health Forum Protecting patients' medical information in the digital age is no easy feat. |
The Motley Fool
March 31, 2011
Brian Orelli |
Hepatitis C Drugs Heat Up The current hepatitis C drugs stink. Who's ahead in the race to find new ones? |
Reason
May 2003
Charles Paul Freund |
Potter Mouth French director Bertrand Tavernier thinks the special effects in American movies are making French kids dumber. But might that be France's fault? |
Science News
March 28, 2009 |
Science Past For March 28, 1959 Thoughts on patient resocialization in a mental hospital during the 1950s. |
The Motley Fool
February 24, 2011
Brian Orelli |
Profit From Personalized Medicine Pfizer's drug works well, but consider these companies instead. |
InternetNews
June 19, 2007
Sean Michael Kerner |
Chambers: We're Not Plumbers Anymore Cisco CEO reveals his thoughts about where the carrier market is going, what role Cisco will play in it and where open source fits in. |
Parameters
Summer 2006
Lou DiMarco |
Losing the Moral Compass: Torture and Guerre Revolutionnaire in the Algerian War Torture also has been the subject of much domestic political debate in the US. The French experience in Algeria from 1954 to 1962 is one of the clearest examples of how ill-conceived interrogation techniques contributed directly to the strategic failure of a counterinsurgency and the success of an insurgency. |
The Motley Fool
January 19, 2012
Brian Orelli |
New Hep C Data Impressive, but It's Not There Yet All-oral treatment still has a ways to go. |
Inc.
July 1, 2003
Patrick J. Sauer |
Bayou Boycott Spurs Buying Anti-French sentiment in Louisiana proves to be a boon for small business. |
The Motley Fool
August 10, 2010
Ryan McBride |
Vertex's Telaprevir Clears Hurdle, Could Halve Treatment Times for Hepatitis C Study results are positive. |
BusinessWeek
September 12, 2005 |
Paris Fences Off Strategic Industries France's center-right government said that it will block foreign acquisitions of French companies in 10 "strategic" industries, including defense, military-related technologies, biotechnology, information security, and the casino business. |
Pharmaceutical Executive
April 1, 2012
Feam & Lagus |
Providing Access Now While regulatory frameworks and medical practices differ between countries, many patients still need early access to new drugs. Industry can help. |
InternetNews
February 5, 2009
Sean Michael Kerner |
Cisco Optimistic It Can Avoid Big Layoffs Cisco reports lower second quarter earnings, but CEO Chambers claims no major layoffs are planned. |
InternetNews
June 3, 2010 |
UofL Web Site Exposes Patients' Personal Info A doctor at the University of Louisville Hospital set up an internal Web site and data base to track and monitor kidney dialysis patients. The problem is the site wasn't password protected. |
Military History
November 2007
Dennis Showalter |
The Day of Doom: The Battle of Gravelotte/Saint-Privat On a single day in 1870, Europe's two greatest armies nearly annihilated each other in an epic slaughter that would not be matched until the stalemates of World War I. |
The Motley Fool
September 8, 2010
Brian Orelli |
You Must Realize This Drug Works by Now Vertex concludes its phase 3 trials with another win. |
BusinessWeek
November 29, 2004
John Rossant |
France's Industrial Power Trip Paris can't stop interfering with the economy -- and that's bad news for Europe. |
InternetNews
May 22, 2007
Sean Michael Kerner |
Chambers: The Network is The Power of Us Cisco's CEO testifies to the power of social networking and Web 2.0 as the engine of productivity. |
Chemistry World
June 4, 2015
Thadchajini Retneswaran |
Microfluidic approach to personalised cancer treatment US scientists have developed an innovative microfluidic assay that can accurately predict how patients with a certain type of blood cancer will respond to an anticancer drug. |
Chemistry World
March 4, 2011
Elinor Richards |
Laser treatment for late-stage cancer Scientists from China, the US and Peru claim to have successfully treated late-stage breast cancer patients using laser immunotherapy to stimulate patients' own immune systems to fight the cancer. |
The Motley Fool
September 7, 2010
Luke Timmerman |
Vertex Nails Third Big Trial With Hepatitis C Drug And in the toughest patients to treat, too. |
Fast Company
April 2012
Christina Chaey |
Srikant Iyer Streamlines Patient Care In Hectic Emergency Rooms This health-care innovator uses a different kind of triage system to identify who is very ill and who is mildly ill, keeping emergency room care moving. |
Chemistry World
September 17, 2009
Ned Stafford |
Food supplement fights HIV A medical nutritional supplement can slow the decline in immunity in HIV-positive patients, according to clinical trials results presented this week. |
The Motley Fool
February 7, 2005
Seth Jayson |
French Fry Google French grousing about trademark infringement by search companies may put a cramp in revenues. Should investors be worried? |
Outside
March 2006
Lindsay Yaw |
Clearing the Air Oxygen chambers allow you to simulate the world's altitude extremes. But should you? Depends on what you're after. |
Chemistry World
June 14, 2012
Andrew Turley |
Good signs for Merck & Co insomnia pill In Phase III trials, insomnia drug candidate suvorexant performed well, reducing the time patients needed to fall asleep and increasing the total time sleeping, with some patients benefitting from the very first night of treatment. |
BusinessWeek
June 10, 2010
John Glover |
France Suddenly Looks Risky Could France be the next to fall? |
Job Journal
June 12, 2005
Michael Kinsman |
Career Pros: France's 35-Hour Mistake France admits its shortened workweek was a faux pas. |
BusinessWeek
October 6, 2003
John Rossant |
The Real War Is France vs. France Resentment of the U.S. is being challenged by a growing cadre of French thinkers. |
The Motley Fool
August 29, 2011
Brian Orelli |
Drug Approved for Few Patients -- but That's OK The age of personalized medicine is upon us. Earlier this month, the FDA approved Roche's melanoma drug Zelboraf for patients with a specific mutation in BRAF. And on Friday, the agency approved Pfizer's Xalkori for lung cancer patients that are ALK-positive. |
Fast Company
July 2005
Greg Goth |
Escape From the Chamber of Horrors The pillars of local business, the Chambers of Commerce, aren't very responsive or relevant anymore to many executives. In some cities, "local hours" have become the mechanism to keep business local. |
InternetNews
March 22, 2006
Nicholas Carlson |
A French Crack at FairPlay The French government thinks it's an inalienable human right to be able to play any digital music file on any digital music player, but Apple Computer said such a right could only be part of a "culture of piracy." |
BusinessWeek
October 27, 2003
John Rossant |
Give This Employment Policy The Guillotine France's 35-hour workweek has been a disaster -- so why is it intact? |
American Journal of Nursing
September 2011
Adams & Tolich |
Original Research: Blood Transfusion: The Patient's Experience This study therefore sought to identify how well patients understand the role of blood transfusion in their treatment and whether it causes them discomfort. |
